Research progress of exosomes as drug carriers in cancer and inflammation

Qixiang Feng,Yu Zhang,Yuelin Fang,Xinru Kong,Zhijing He,Jianbo Ji,Xiaoye Yang,Guangxi Zhai

DOI: https://doi.org/10.1080/1061186X.2022.2162059

2023-01-05

Journal of Drug Targeting

Abstract:Extracellular vesicles (EVs) could be produced by most cells and play an important role in disease development. As a subtype of EVs, exosomes exhibit suitable size, rich surface markers and diverse contents, making them more appealing as potential drug carriers. Compared with traditional synthetic nanoparticles, exosomes possess superior biocompatibility and much lower immunogenicity. This work reviewed the most up-to-date research progress of exosomes as carriers for nucleic acids, proteins and small molecule drugs for cancer and inflammation management. The drug loading strategies and potential cellular uptake behaviour of exosomes are highlighted, trying to provide reference for future exosome design and application. Exosomes are secreted by a variety of cells and play an important role in the process of inter-cell communication. This paper provides a comprehensive review focussing on the up-to-date applications of exosomes as carriers of nucleic acids, proteins and small molecule drugs for cancer and inflammation management. This paper briefly introduces the basic properties of exosomes, from definition, biogenesis to cellular uptake manners. Various strategies to enable exosomes to efficiently load cargoes are highlighted. Problems to be solved when using exosomes to deliver drugs are discussed.

pharmacology & pharmacy